ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Multiple Sclerosis
Sclerosis
Chronic Progressive Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Autoimmune Diseases
Neoplasm Metastasis
Cognitive Dysfunction

Multiple Sclerosis (MS) trials near San Francisco, CA, USA:

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (BEAT-MS)

of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...

Enrolling
Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Biological: Best Available Therapy (BAT)

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Palo Alto, California, United States and 19 other locations

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects with Refractory Primary and Secondary Progressive Multiple...

Enrolling
Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive
Drug: Standard lymphodepletion regimen
Biological: KYV-101

Phase 2

Kyverna Therapeutics

Palo Alto, California, United States

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP...

Enrolling
Amyotrophic Lateral Sclerosis (ALS)
Multiple Sclerosis (MS)
Drug: 18F-OP-801

Phase 1, Phase 2

Ashvattha Therapeutics
Ashvattha Therapeutics

San Francisco, California, United States and 2 other locations

This is an open label, Phase 1b, multiple ascending dose, and dose-expansion study of IDP-023 administered in combination with interleukin-2 ...

Not yet enrolling
Non-Active Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
Drug: Interleukin-2
Drug: IDP-023

Phase 1

Indapta Therapeutics

San Francisco, California, United States and 3 other locations

This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...

Enrolling
Multiple Sclerosis
Drug: Ofatunumab

Phase 4

Novartis
Novartis

San Francisco, California, United States and 2 other locations

Newly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients will be treate...

Active, not recruiting
Relapsing Multiple Sclerosis
Clinically Isolated Syndrome
Drug: Ocrelizumab

Phase 4

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States

In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

Phase 2

Biogen
Biogen

Berkeley, California, United States and 76 other locations

A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis...

Enrolling
Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive
Biological: KYV-101 anti-CD19 CAR-T cell therapy
Drug: Standard lymphodepletion regimen

Phase 1

Stanford University
Stanford University

Palo Alto, California, United States

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Interferon beta-1a
Drug: Placebo capsule

Phase 3

Novartis
Novartis

San Francisco, California, United States and 107 other locations

This study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple...

Enrolling
Multiple Sclerosis
Clinically Isolated Syndrome
Drug: Ocrelizumab

Phase 4

Roche
Roche

San Francisco, California, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems